| Literature DB >> 32278452 |
Abstract
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a heteromorphic disease with both medical and surgical aspects to its treatment. CRSwNP is a chronic inflammatory condition with exacerbations that can be controlled through surgical and/or medical interventions, including biological agents. The role of biological agents in the treatment of CRSwNP as well as the patient characteristics that make suitable candidates for biologics are discussed.Entities:
Keywords: Benralizumab; Biologic; Chronic rhinosinusitis; Dupilumab; Mepolizumab; Nasal polyposis; Omalizumab; Reslizumab
Mesh:
Substances:
Year: 2020 PMID: 32278452 DOI: 10.1016/j.iac.2019.12.006
Source DB: PubMed Journal: Immunol Allergy Clin North Am ISSN: 0889-8561 Impact factor: 3.479